Quality of Life and Psychological Vulnerability in Patients With RH+ Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Durvalumab (MEDI4736) and Tremelimumab in Hormone Receptor-positive, Hypermutated Metastatic Breast Cancer Identified by Whole Exome Sequencing
- Status
- COMPLETED
- Phase
- PHASE2
BP-C1 in Short-term Treatment of Thai Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fulvestrant in Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE4
Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Southeast Netherlands Advanced Metastatic Breast Cancer Registry
- Status
- RECRUITING
- Phase
- N/A
Study to Evaluate CCS1477 in Advanced Tumours
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRP
- Status
- COMPLETED
- Phase
- PHASE2
T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study to Determine the Utility of FES-PET in the Prediction of Response to Fulvestrant in Women With Estrogen Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
An Early Phase Study of Abraxane Combined With Phenelzine Sulfate in Patients With Metastatic or Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD
- Status
- TERMINATED
- Phase
- PHASE2
Pembrolizumab in Combination With Paclitaxel in the Hormone Receptor-positive Metastatic Breast Cancer With High Tumor Mutational Burden Selected by Whole Exome Sequencing: Korean Cancer Study Group Trial (KCSG BR20-16)
- Status
- UNKNOWN
- Phase
- PHASE2
A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Nurse AMIE: A Tablet Based Supportive Care Platform in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
S 81694 Plus Paclitaxel in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2